Schedule iii

By

21-08-2026

Cannabis Stocks Rally as Investors Bet on DEA Rescheduling Outcome

MSOS, the AdvisorShares Pure US Cannabis ETF, is trading at its highest levels of 2026, and the timing is not incidental. A DEA administrative hearing set for June 29 will examine whether marijuana

• Cannabis Stocks

By

30-05-2026

Indiana's AG Challenges Federal Cannabis Rescheduling, Putting Industry Policy at Risk

Indiana Attorney General Todd Rokita has joined a multistate legal action against the Trump administration, targeting the federal government's move to reclassify marijuana to a lower schedule under

• Todd Rokita

By

03-05-2026

Trump's Cannabis Rescheduling Order Reshapes Federal Policy, but Falls Far Short of Legalization

When President Trump signed an executive order in December 2025 directing the Attorney General to expedite the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances

• Trump

By

28-04-2026

Federal Cannabis Rescheduling Finally Arrives - But Only for Medical Operators

On April 23, 2026, the Department of Justice placed state-licensed medical cannabis into Schedule III of the Controlled Substances Act, ending decades of uniform federal prohibition for an industry

• Federal Cannabis Rescheduling

By

28-04-2026

Federal Government Moves Medical Marijuana Out of Its Most Restrictive Drug Category

For more than half a century, the federal government treated marijuana the same as heroin. That just changed - at least partly. An order signed April 23 by Acting Attorney General Todd Blanche

• medical marijuana